Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | RXRA | P19793 | 1/20 | 0.46 |
| ▸ | RXRB | P28702 | 1/20 | 0.46 |
| ▸ | GPR3 | P46089 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 5/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20747274 | 0.92 | NPC1 (0.47) | NPC1RAB9AL3MBTL1RXRARXRB | |
| SCHEMBL21032513 | 0.85 | GPR3 (0.47) | NPC1RAB9AL3MBTL1RXRARXRB | |
| SCHEMBL21032514 | 0.85 | GPR3 (0.47) | NPC1RAB9AL3MBTL1RXRARXRB | |
| SCHEMBL17904035 | 0.81 | RXRA (0.48) | NPC1RAB9AL3MBTL1RXRARXRB | |
| SCHEMBL19129975 | 0.81 | RXRA (0.48) | NPC1RAB9AL3MBTL1RXRARXRB | |
| SCHEMBL16373476 | 0.79 | GPR3 (0.70) | NPC1RAB9AL3MBTL1RXRARXRB | |
| SCHEMBL23847258 | 0.77 | RXRA (0.48) | NPC1RAB9AL3MBTL1RXRARXRB | |
| SCHEMBL12152361 | 0.77 | ATM (0.49) | NPC1RAB9AL3MBTL1POLBGAA | |
| SCHEMBL12419781 | 0.76 | GPR3 (0.64) | NPC1RAB9AL3MBTL1RXRARXRB | |
| SCHEMBL17904072 | 0.76 | RXRA (0.42) | NPC1RAB9AL3MBTL1RXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11091452-B2 | Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound | ZEON CORPORATION (JP) | 2021-08-17 | — | — | US | disclosed |
| US-10620352-B2 | Circularly polarized light separating film and method for producing same | ZEON CORPORATION (JP) | 2020-04-14 | — | — | US | disclosed |
| US-20200048213-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | ZEON CORPORATION (JP) | 2020-02-13 | — | — | US | disclosed |
| US-20180143361-A1 | CIRCULARLY POLARIZED LIGHT SEPARATING FILM AND METHOD FOR PRODUCING SAME | ZEON CORPORATION (JP) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048213-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | PDE8A, MAPT, PLK4 | NPC1 3200/4885RAB9A 3436/4885L3MBTL1 2549/4885 |
| US-11091452-B2 | Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound | PDE8A, MAPT, PLK4 | NPC1 3200/4885RAB9A 3436/4885L3MBTL1 2549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.